End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
54.3 TWD | -0.73% | -2.51% | -21.65% |
03-20 | CHO Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | CHO Pharma, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tsung I Wu
CEO | Chief Executive Officer | - | - |
Chao-Long Chen
CHM | Chairman | - | 17-12-26 |
Yi Pei Chou
DFI | Director of Finance/CFO | - | 16-03-27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Hsing Tsai
BRD | Director/Board Member | 66 | 13-05-26 |
Hsuan Ta Liu
BRD | Director/Board Member | - | 19-06-05 |
Chao-Long Chen
CHM | Chairman | - | 17-12-26 |
Director/Board Member | - | 16-11-20 | |
Ying Hsin Tsai
BRD | Director/Board Member | - | 16-11-20 |
Ming Che Sih
BRD | Director/Board Member | - | 19-06-05 |
Chin Lieh Wu
BRD | Director/Board Member | - | 19-06-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 214,011,000 | 214,000,500 ( 100.00 %) | 0 | 100.00 % |
Company contact information
CHO Pharma, Inc.
7/F, Building C 99 Lane 130, Yanjiu Road Section 1
115 71, Taipei
+
http://www.chopharma.comSector
1st Jan change | Capi. | |
---|---|---|
-21.65% | 358M | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- 6586 Stock
- Company CHO Pharma, Inc.